Page 186 - பிரேசிலியன் ப்ரெஸிடெஂட் ஜெயர் போல்சனாரோ News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Science’s COVID-19 reporting is supported by the Heising-Simons Foundation. Despite safety concerns, the Brazilian Health Regulatory Agency (Anvisa) reversed itself last week and voted to allow a trickle of Sputnik V, the Russian-made COVID-19 vaccine, into the country. Only 928,000 doses will be imported just a fraction of the total requested by a group of state governors and the agency imposed stringent measures to reduce supposed health risks and monitor the vaccine’s safety and efficacy. In April, with Brazil facing a massive COVID-19 surge and a scarcity of vaccine, Anvisa vetoed a previous import request, citing concerns that the vaccine contains adenoviruses that could replicate and harm vaccinated people. The decision sparked a lawsuit threat by Sputnik V’s manufacturer, the Gamaleya Research Institute of Epidemiology and Microbiology, and drew criticism from some scientists. But on 4 June, four of Anvisa’s five directors decided to allow the importation of Sputnik

Jorge kalilSergio rezendeAndre pennerAlex machadoJair bolsonaroGustavo mendesHeising simons foundationGamaleya research institute of epidemiologyBrazilian health regulatory agency anvisaWorld health organizationBrazilian health regulatory agencyGamaleya research instituteBrazilian president jair bolsonaroFederal universityஜார்ஜ் கலில்செர்ஜியோ ரேஜெந்தே